RxDoctor Payments Data

Rovin Santos, NP

Family · Los Angeles, CANPI 1306492368

Payments from drug & device makers

$26in general payments, 2019–2025

Across 1 payment — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Next Science LLC$26

What the payments were for

  • Food & beverage$26100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Next Science LLC1$26

How this compares

$26 in reported general payments places this provider in the 5th percentile of 10,634 family providers in California.

See all family providers in California

Medicare billing

Part B allowed, 2024
$2,676,527
Medicare patients
1,040
Services billed
12,361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SantylCollagenase Clostridium Hist.68$37,509

Paid to pharmacies, not to this prescriber.

Other family in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →